Today: 29 June 2026
Browse Category

Stock Market 30 December 2025

Corcept stock slides nearly 9% as FDA decision deadline arrives — what’s driving CORT today

Corcept stock slides nearly 9% as FDA decision deadline arrives — what’s driving CORT today

Corcept Therapeutics shares fell 8.9% to $72.72 in early afternoon trading Tuesday as investors awaited the FDA’s decision on relacorilant, due later in the day. SEC filings showed CEO Joseph Belanoff and Chief Business Officer Gary Charles Robb exercised stock options and withheld shares for taxes. About 897,000 shares changed hands. The drop outpaced declines in major biotech indexes.
30 December 2025
··
Equinox Gold stock climbs as gold rebounds — here’s what’s moving EQX today

Equinox Gold stock climbs as gold rebounds — here’s what’s moving EQX today

Equinox Gold shares rose 2.2% to around $14.30 on Tuesday as gold prices rebounded, following a sharp drop the previous day. About 2.2 million shares traded, with the stock moving between $14.18 and $14.58. Investors are watching for Federal Reserve minutes later in the day for signals on 2026 rate cuts. No major company news since Equinox announced its Brazil asset sale on Dec. 14.
30 December 2025
··
Target stock slips today as activist pressure stays in focus — what investors are watching next

Target stock slips today as activist pressure stays in focus — what investors are watching next

Target shares fell 0.7% to $97.38 in midday trading Tuesday, underperforming a weaker retail sector. The move follows reports that hedge fund Toms Capital Investment Management has taken a significant, undisclosed stake as Target prepares for a CEO transition in February. Investors await filings that could reveal TCIM’s intentions. Target shares are down more than 28% in 2025.
30 December 2025
·
IREN stock slips today as year-end tech jitters hit AI data-center plays

IREN stock slips today as year-end tech jitters hit AI data-center plays

IREN shares dropped 1.4% to $38.87 by midday Tuesday, underperforming bitcoin, which rose 0.7%. The move follows IREN’s early-December share sale and $2.3 billion convertible note issue, fueling investor focus on funding and dilution. Trading volume reached about 10.7 million shares. Core Scientific fell 1.2%, while Marathon Digital was little changed.
30 December 2025
Why Newmont stock is up today: gold rebounds and Fed minutes loom

Why Newmont stock is up today: gold rebounds and Fed minutes loom

Newmont shares rose 2.7% to $102.48 by midday Tuesday, rebounding after Monday’s nearly 6% drop. The move followed a Raymond James price target hike and steadier gold prices, with spot gold up 0.9% after its sharpest fall since October. Trading volume reached about 3.36 million shares. Investors awaited the Federal Reserve’s December minutes for signals on 2026 interest rates.
30 December 2025
···
Pan American Silver stock today: PAAS climbs as silver rebounds after margin shakeout

Pan American Silver stock today: PAAS climbs as silver rebounds after margin shakeout

Pan American Silver shares rose 2.1% to $53.36 by midday Tuesday, following a 4.7% rebound in spot silver after Monday’s steep drop. About 2.6 million shares traded between $52.44 and $54.32. CME Group raised futures margin requirements after the close on Dec. 29, which helped trigger the earlier selloff. Investors await Fed minutes later Tuesday and Pan American’s Feb. 18 results.
30 December 2025
··
Newmont stock rises as gold rebounds; Raymond James lifts $111 target

Newmont stock rises as gold rebounds; Raymond James lifts $111 target

Newmont Corp shares climbed 2.2% to $102.00 in midday trading Tuesday, rebounding after a 5.6% drop Monday as gold prices steadied. Spot gold rose 0.9% to $4,369.59 an ounce, recovering from its sharpest daily loss since October. Raymond James raised its price target on Newmont to $111. CEO Tom Palmer will step down Dec. 31, with Natascha Viljoen set to take over Jan. 1.
30 December 2025
··
Edgewise Therapeutics stock steady midday after $3 million insider sale filing — what’s next for EWTX

Edgewise Therapeutics stock steady midday after $3 million insider sale filing — what’s next for EWTX

Edgewise Therapeutics shares rose 0.2% to $24.68 after a Form 144 filing showed officer Robert Michael Carruthers sold 116,665 shares for about $3.04 million on Dec. 26. The stock traded between $24.40 and $24.92 midday. The sale followed a Dec. 24 update on the company’s Phase 2 trial of EDG-7500 in hypertrophic cardiomyopathy. Biotech stocks broadly traded lower.
30 December 2025
·
AST SpaceMobile stock jumps 6% today as launch cadence and insider buy lift sentiment

AST SpaceMobile stock jumps 6% today as launch cadence and insider buy lift sentiment

AST SpaceMobile shares climbed 6.5% to $76.09 in midday trading Tuesday after the company said its BlueBird 6 satellite is expected to begin operations in the coming weeks. COO Shanti B. Gupta outlined plans for faster launches into early 2026. Director Keith Larson bought 625 shares last week under a pre-arranged plan, according to a U.S. regulatory filing.
30 December 2025
··
1 … 961 962 963 964 965 … 1,600

Stock Market Today

  • IREN Limited Shares Fall 21% Amid Golden State Warriors Sponsorship and AI Expansion
    June 28, 2026, 6:36 PM EDT. IREN Limited (NASDAQ:IREN) shares dropped 21.3% to $47.21, marking five consecutive down days and highlighting investor concerns despite the new multi-year Golden State Warriors jersey sponsorship deal worth over $50 million annually. This sponsorship represents only about 1.1% of IREN's $4.4 billion annual recurring revenue (ARR) target, emphasizing the company's larger focus on AI infrastructure. IREN recently secured a $3.65 billion GPU financing facility linked to its Microsoft AI cloud contract and plans a $1.6 billion hardware purchase from Dell Technologies for a $3.4 billion managed AI cloud deal. Short interest stands at 19.74% of float. The stock now mirrors delivery of AI infrastructure capacity more than branding efforts, with a median analyst target of $82.50, suggesting upside potential amid execution risks.

Latest articles

IREN Limited (NASDAQ:IREN) slides as Warriors badge faces AI revenue test

IREN Limited (NASDAQ:IREN) slides as Warriors badge faces AI revenue test

29 June 2026
IREN Limited (NASDAQ:IREN) plunged 21.3% to $47.21 over five straight down days despite announcing a record $50M+ annual Warriors jersey deal, as investors focused on the company’s not fully contracted $4.4B target ARR and high short interest at 19.74% of float, with Friday’s close near the lowest analyst target.
Kroger (NYSE:KR) chicken alert puts Private Selection label controls in focus

Kroger (NYSE:KR) chicken alert puts Private Selection label controls in focus

29 June 2026
Kroger (NYSE:KR) faces scrutiny after a USDA alert flagged mislabeled Private Selection Honey Dijon chicken in nine states, but with no confirmed adverse reactions and the product already off shelves, the stock closed Friday at $57.73, down 5 cents; any expansion of affected lots or confirmed cases could alter risk for investors.
Go toTop